Claim: A Japanese company found that the antiparasitic drug ivermectin showed an "antiviral effect" against the omicron variant in a lab setting. Reuters has corrected a story in which it "misstated" that the drug was effective in a phase 3 clinical trial with human subjects. Some social media users have repeated Reuters' reporting error but have not repeated the correction.
Fact-check: Social Media Posts Repeat Inaccurate Reporting on Ivermectin and Omicron - FactCheck.org
Verdict: a japanese company found that the antiparasitic drug ivermectin showed an "antiviral effect" against the omicron variant in a lab setting. reuters has corrected a story in which it "misstated" that the drug was effective in a phase 3 clinical trial with human subjects. some social media users have repeated reuters' reporting error but have not repeated the correction.
Organisation: FactCheck.org
Author: D'Angelo Gore
Date published: 2022-02-02T21:19:38